PDCD4 and systemic sclerosis: Mir-21, together with miR-200c, were found to be increased in SSc patients [58,59,60,89] and mediate the PDCD4 (programmed cell death protein 4)/PTEN (homologous phosphatase and tensin homolog) pathway, resulting in the inhibition of ROS oxidative stress [88,90].